← Insider buys
GLUE

Monte Rosa Therapeutics, Inc. · Healthcare

President and CEO Markus Warmuth sold $106K of Monte Rosa Therapeutics, Inc.

Sold$106,253
$19.44Price
5,466Shares
−1%Stake

What GLUE did after the filing

Filed Jun 2Copier in Jun 3
The stock from Wed, Jun 3 open, $17.87
+37.4%
S&P 500, same days
−2.0%

Measured over 30 trading days, to the Jul 17 close.

Traded Mon, Jun 1. Filed Tue, Jun 2, 4:05 PM ET, after the close. Returns use the Jun 3 open and the Jul 17 close. Not investment advice.